Cardiol Common Stock Total Equity vs Net Tangible Assets Analysis
| CRDL Stock | | | CAD 1.85 0.06 3.14% |
Cardiol Therapeutics financial indicator trend analysis is way more than just evaluating Cardiol Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cardiol Therapeutics is a good investment. Please check the relationship between Cardiol Therapeutics Common Stock Total Equity and its Net Tangible Assets accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Common Stock Total Equity vs Net Tangible Assets
Common Stock Total Equity vs Net Tangible Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cardiol Therapeutics Common Stock Total Equity account and
Net Tangible Assets. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Cardiol Therapeutics' Common Stock Total Equity and Net Tangible Assets is 0.85. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Net Tangible Assets in the same time period over historical financial statements of Cardiol Therapeutics Class, assuming nothing else is changed. The correlation between historical values of Cardiol Therapeutics' Common Stock Total Equity and Net Tangible Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Cardiol Therapeutics Class are associated (or correlated) with its Net Tangible Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Tangible Assets has no effect on the direction of Common Stock Total Equity i.e., Cardiol Therapeutics' Common Stock Total Equity and Net Tangible Assets go up and down completely randomly.
Correlation Coefficient | 0.85 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.
Most indicators from Cardiol Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cardiol Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
As of the 6th of August 2025,
Issuance Of Capital Stock is likely to grow to about 31.5
M, while
Selling General Administrative is likely to drop about 16.4
M.
Cardiol Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Cardiol Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cardiol Therapeutics fundamental ratios Accounts
When determining whether Cardiol Therapeutics is a strong investment it is important to analyze Cardiol Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiol Therapeutics'
future performance.
For an informed investment choice regarding Cardiol Stock, refer to the following important reports: Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardiol Therapeutics Class. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
You can also try the
Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Please note, there is a significant difference between Cardiol Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiol Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiol Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.